Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by ForestHasEyeson Apr 01, 2019 4:11pm
202 Views
Post# 29565943

RE:THREE OF THE SAFEST POT STOCKS TO OWN IN 2019

RE:THREE OF THE SAFEST POT STOCKS TO OWN IN 2019
Daredevil1964 wrote:

Canada approved its use last year. The Farm Bill legalized industrial hemp, and CBD. More U.S. states have approved its recreational and/or medicinal use. Americans have become more accepting of marijuana… the list goes on. No wonder analysts like Cowen & Co. say the marijuana market could be worth as much as $75 billion by 2030.

While the story is still one of the most controversial, it’s also likely to be one of the most rewarding for patient, long-term investors – especially in these three notable stocks.

Pot Stock No. 1 – Canopy Growth (CGC)

At the moment, Canopy Growth has 4.3 million square feet of licensed production capacity, and forecasts 5.6 million square feet by the end of 2019. It also anticipates producing up to 500,000 kilograms at peak capacity. Better yet, over the last year, Constellation Brands invested $4 billion in the company, as it seeks to diversify its business with marijuana. Plus, we expect for the company to be quite active on the acquisition front with more than $4.3 billion in cash.

Pot Stock No. 2 – Aphria Inc. (APHA)

The stock may have pulled back in recent weeks thanks to the market pullback, and a short-seller report. However, it could still see a partnership. For one, it’s expected to be one of the biggest cannabis growers with potential peak annual production of 255,000 kilograms. And two, the company just added Tom Looney to its Board of Directors. He spent the last three decades in the alcohol industry, most notably as the President of Diageo’s U.S. Spirits and Canada division. Diageo has also been rumored to be seeking a cannabis partner.

Better yet, the company expects to grow sales by more than 400% this year.

Pot No. 3 – Aurora Cannabis (ACB)

The company has been forecasting 570,000 kilograms of peak yearly output. There are reports that it could eventually yield up to a million kilograms of cannabis per year. While a partnership with Coca-Cola never materialized, such production targets could open the company up for likely partnerships. Better yet, Wall Street estimates the company could see a 600% increase in sales year over year in 2019.

The best part – most marijuana stocks are extremely oversold on the latest market pullback.

But with patience and $75 billion market potential, marijuana stocks are some of the best stocks to consider owning for the long haul. Stay tuned for more.


BUMP Thank-You Daredevil1964 For All Your Good Posts
Cheers;Forest.
Bullboard Posts